Drug Use Investigation for LAMICTAL

• Status: Completed
• Trial end date: 2016-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to grasp actual status of usage of lamotrigine tablet and to collect information for using lamotrigine tablet effectively and safely as well as to grasp onset status of adverse events in pediatric subjects, geriatric subjects, pregnant women, subjects with poor renal and hepatic functions.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: Anticonvulsants; Lamotrigine

Criteria

Inclusion Criteria:

• Subjects with epilepsy having the following seizure types.

• Partial seizures (including secondary generalized seizures)

• Tonic-clonic seizures

• Generalized seizures of Lennox-Gastaut syndrome

Exclusion Criteria:

• None